AquaBounty Technologies, Inc.
AQBAquaBounty Technologies, Inc. is a biotechnology company focused on the development and commercialization of genetically modified aquatic organisms, primarily salmon. The company's flagship product is the AquAdvantage Atlantic salmon, engineered to grow faster than conventional salmon. AquaBounty aims to provide sustainable and efficient seafood solutions through innovative genetic technology, addressing global food security and reducing the environmental impact of aquaculture.
Company News
Shentel has appointed Angela M. Olsen as Vice President-Legal and General Counsel, bringing over 25 years of legal experience from various corporate and government roles.
AquaBounty Technologies (AQB) delivered earnings and revenue surprises of -7.75% and 4.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Immunome (IMNM) delivered earnings and revenue surprises of 57.50% and 74.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cara (CARA) delivered earnings and revenue surprises of -47.37% and 5.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Arcus Biosciences (RCUS) delivered earnings and revenue surprises of 94.85% and 454.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
